These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4628577)

  • 1. Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity.
    Thomas D; Woodrooffe JG; Mosedale B; Ward PD; Zola H; Edwards DC; Balner H
    Clin Exp Immunol; 1972 Aug; 11(4):569-78. PubMed ID: 4628577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the indirect fluorescent antibody technique in assessing the activity of antilymphocytic sera and antilymphocytic globulins.
    Thomas D; Mosedale B; Zola H
    Clin Exp Immunol; 1971 Jun; 8(6):987-91. PubMed ID: 4997074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of the rosette inhibition test in the preparation and assay of antilymphocytic globulin.
    Hogg DF; Clunie GJ; Morton H; Hegh V
    Aust N Z J Surg; 1973 Sep; 43(2):188-92. PubMed ID: 4618099
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of antilymphocyte serum for use in dogs and test of its immunosuppressive potency.
    Rowiński W; Szmidt J; Brühl A; Dziedziul S; Tupalska B; Baraniewski H; Grupińska E; Opertowski A; Nielubowicz J
    Pol Med J; 1971; 10(2):425-30. PubMed ID: 4934232
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum.
    Sell K; Woody J; Smith J; Darrow C; Kayhoe D
    Transplant Proc; 1973 Mar; 5(1):541-7. PubMed ID: 4633091
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet complement fixation: an in vitro test of the immunosuppressive activity of antilymphocyte globulin.
    Balfour IC; Pegrum GD; Williams GB; Balner H
    Transplantation; 1972 Sep; 14(3):308-10. PubMed ID: 4629282
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive properties of heterologous antilymphocytic sera prepared against thymocyte soluble fraction. 1.
    Singla O; Barth RF; Jeejeebhoy HF
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1203-6. PubMed ID: 4560529
    [No Abstract]   [Full Text] [Related]  

  • 8. Uptake of antilymphocyte globulin by human peripheral lymphocytes.
    Brain P; Marston RH
    Clin Exp Immunol; 1973 Mar; 13(3):423-6. PubMed ID: 4633851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimacaque thymocyte globulins. Toxicity and immunodepressive effect in the human species.
    Dubernard JM; Rifle G; Bonneau M; Touraine JL; Revillard JP; Traeger J
    Transplantation; 1974 Jul; 18(1):71-4. PubMed ID: 4209653
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of tolerance with antilymphocytic serum.
    Lance EM; Medawar PB
    Transplant Proc; 1969 Mar; 1(1):429-32. PubMed ID: 4944254
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H; Dersjant H; van Bekkum DW
    Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666
    [No Abstract]   [Full Text] [Related]  

  • 13. The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.
    Allardyce RA; Anderson NF; Vaerman JP; James K
    Clin Exp Immunol; 1973 Feb; 13(2):263-78. PubMed ID: 4120853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosette formation by peripheral lymphocytes. II. Inhibition of the phenomenon.
    Brain P; Gordon J
    Clin Exp Immunol; 1971 Mar; 8(3):441-9. PubMed ID: 4995960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescent titration of thymocyte reactive membrane antibodies as a suggested in vitro correlate of the immunosuppressive potency of anti-human thymocyte globulin.
    Ablin RJ; Morrell RM
    Eur Surg Res; 1976; 8(2):140-7. PubMed ID: 821756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
    Kelly GE; Sheil AG; Mears DC
    Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of anti-dog lymphocytic globulin raised with two cell types and immunization schedules.
    Collste LG; Groth CG; Kashiwagi N; Schantz B; Svehag SE
    Acta Chir Scand; 1972; 138(8):775-80. PubMed ID: 4565722
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective and ineffective systems of in vitro testing for antilymphocyte globulin (ALG) potency: correlation of mixed agglutination and primate skin graft testing.
    Millington M; Thomas FT; Berry R; Thomas JM; Lee HM
    Surg Forum; 1977; 28():329-31. PubMed ID: 103222
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the assessment and titration of antilymphocytic sera "in vitro" and "in vivo".
    Momchilov B; Gencheva G
    Dev Biol Stand; 1974; 27():229-32. PubMed ID: 4618535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.